Nghiem, Paul
- University of Washington · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #2,454
- Rising Star
- Sustained Excellence
- Program Leader
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$2.6M
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#2,454
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Nghiem, Paul as a PI. Multi-PI records show the full award amount for context.
- 5P01CA225517-05P01Contact PIImmunobiology and Immune Therapyfor Merkel Cell CarcinomaUniversity of Washington · Internal Medicine (NIH department code)$2.6Maward amount
Award organization
Organizations that administered FY2023 awards listing Nghiem, Paul as a PI.
FY2023 award administered by University of Washington (WA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardUniversity of Washington
- 2007$500K Cumulative Funding
- 2009$1M Cumulative Funding
- 2010$2M Cumulative Funding
- 2010Entered Top 50% NationallyRanked #7129
- 2013$5M Cumulative Funding
- 2013Entered Top 25% NationallyRanked #3465
- 2015Program/Center Grant Leader
- 2016$10M Cumulative Funding
- 2019Entered Top 10% NationallyRanked #1552
- 2020Entered Top 5% NationallyRanked #357
- 2023$25M Cumulative Funding